Home » Topics » BioWorld Science

BioWorld Science
RSS

Polyphor temporarily halts enrollment in phase III studies of murepavadin

May 13, 2019

Gene editing restores skin functionality in blistering disease

May 13, 2019

SHR-1210 plus capecitabine and oxaliplatin shows promising safety and efficacy in GC/GEJ

May 13, 2019

Investigators present phase II data for CBT-001 for the treatment of pterygia

May 13, 2019

AAI 2019: T-cell therapy could be brought within reach of "virtually all" patients

May 13, 2019

LY-3154207 demonstrates linear plasma PK and promising safety in healthy volunteers

May 13, 2019

Merck & Co. discovers dual TBK1/IKBKE inhibitors

May 13, 2019

NIH initiates LATITUDE study to evaluate long-acting HIV medication

May 13, 2019

FORMA Therapeutics identifies new HDAC6 inhibitors

May 13, 2019

OliX expands ocular disease pipeline with new OLX-304A program in retinitis pigmentosa

May 13, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...